• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH 11.1% 0.5¢

ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company’s lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson’s disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase 2 clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATH
Upcoming presentation dates and time at AAN, with preliminary phase 2 timeline
16:07 18 2.7K
16:07 Last post  shlok Comments Created with Sketch.  18  Views Created with Sketch.  2.7K 
ATH
A new MSA update
16/03/24 1 405
16/03/24 Last post  Scottsmyname Comments Created with Sketch.  1  Views Created with Sketch.  405 
ATH 16/03/24 48 11K
TRENDING NEWS

BREAKING: RBA keeps interest rate on hold at 4.35% in line with expectations

NEWS
19 Mar 2024
16/03/24 Last post  Scottsmyname Comments Created with Sketch.  48  Views Created with Sketch.  11K 
ATH 14/03/24 0 236
14/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  236 
ATH 07/03/24 1 595
07/03/24 Last post  gumboot Comments Created with Sketch.  1  Views Created with Sketch.  595 
ATH 06/03/24 0 258
06/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  258 
ATH 04/03/24 9 2.5K
04/03/24 Last post  iminvestor101 Comments Created with Sketch.  9  Views Created with Sketch.  2.5K 
ATH 04/03/24 1 422
04/03/24 Last post  groins Comments Created with Sketch.  1  Views Created with Sketch.  422 

See All Discussions arrow Created with Sketch.

Timeline

Notice of Extraordinary General Meeting/Proxy Form
14 Mar 09:08
 
Becoming a substantial holder
07 Mar 08:15
 
Change in substantial holding
06 Mar 08:18
 
Notice Under Section 708A
04 Mar 10:34
 
Application for quotation of securities - ATH
04 Mar 10:29
 
Change in substantial holding
29 Feb 08:09
 
View More arrow Created with Sketch.
(20min delay)
Last
0.5¢
Change
0.001(11.1%)
Mkt cap ! $26.19M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $177.1K 43.22M

Buyers (Bids)

No. Vol. Price($)
5 6530000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 61097700 52
View Market Depth
Last trade - 16.10pm 19/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 12.5 %)
Open High Low Volume
0.4¢ 0.5¢ 0.4¢ 23124792
Last updated 15.14pm 19/03/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.